Mix Peptides
Tirzepatide
Finnrick tested 18 samples of Tirzepatide (GLP-1 and GIP agonist) from Mix Peptides between 23 Oct 2025 and 26 Jan 2026. Test scores average over 4, no score below 3, and at least 6 tests warrant a confident Finnrick Rating of D (Poor).
Finnrick Rating™
Mix Peptides
Tirzepatide
Tested 18 Samples
Last test 26 Jan 2026
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Mix Peptides
Samples are tested in commercial labs
Tests Count
18
Scores
AVGMINMAX
Last
26 Jan 2026
First
23 Oct 2025
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 26 Jan 2026 | View | 30mg | (no batch claim) | 35.3mg | +17.7% | 99.90% | 2025A56-10 | No Label / Silver Crimp / Orange Cap | Lab G | Public | |
| 19 Jan 2026 | View | 60mg | 64.2mg | 52.1mg | -18.8% | 99.95% | 2025A512-10 | White Label / Silver Crimp / Clear Red Cap | Lab E | Public | |
| 19 Jan 2026 | View | 30mg | (no batch claim) | 33.2mg | +10.7% | 99.95% | 2025A56-11 | White Label / Silver Crimp / Orange Cap | Lab E | Public | |
| 13 Dec 2025 | View | 30mg | (no batch claim) | 35.2mg | +17.3% | 99.40% | 2025A56-10 | No Label / Silver Crimp / Orange Cap | Lab G | Public | |
| 13 Dec 2025 | View | 30mg | (no batch claim) | 35.6mg | +18.7% | 99.70% | 2025A56-10 | No Label / Silver Crimp / Orange Cap | Lab G | Public | |
| 13 Dec 2025 | View | 30mg | (no batch claim) | 32.9mg | +9.7% | 99.80% | 2025A56-10 | No Label / Silver Crimp / Orange Cap | Lab G | Public | |
| 13 Dec 2025 | View | 30mg | 33.0mg | 35.4mg | +7.2% | 99.50% | 2025A56-10 | No Label / Silver Crimp / Orange Cap | Lab G | Public | |
| 13 Dec 2025 | View | 30mg | 33.0mg | 34.4mg | +4.2% | 99.40% | 2025A56-10 | No Label / Silver Crimp / Orange Cap | Lab G | Public | |
| 13 Dec 2025 | View | 30mg | (no batch claim) | 35.8mg | +19.3% | 99.50% | 2025A56-10 | No Label / Copper Crimp / Orange Cap | Lab G | Public | |
| 13 Dec 2025 | View | 30mg | (no batch claim) | 33.9mg | +13.0% | 99.80% | 2025A56-10 | No Label / Silver Crimp / Orange Cap | Lab G | Public | |
| 18 Nov 2025 | View | 30mg | 37.1mg | 30.8mg | -17.0% | 99.94% | 2025a56-09 | Silver Label / Silver Crimp / Orange Cap | Lab E | Public | |
| 18 Nov 2025 | View | 60mg | (no batch claim) | 47mg | -21.7% | 82.37% | 2025a512-09 | Silver Label / Silver Crimp / Clear Red Cap | Lab E | Public | |
| 17 Nov 2025 | View | 30mg | (no batch claim) | 27.6mg | -8.0% | 99.75% | 2025B53-10 | No Label / Silver Crimp / Orange Cap | Lab E | Public | |
| 17 Nov 2025 | View | 30mg | (no batch claim) | 29.7mg | -1.0% | 99.79% | 2025A56-09 | No Label / Silver Crimp / Orange Cap | Lab E | Public | |
| 17 Nov 2025 | View | 60mg | 68.6mg | 60.3mg | -12.1% | 97.90% | 2025a512-09 | Silver Label / Silver Crimp / Clear Red Cap | Lab E | Public | |
| 5 Nov 2025 | View | 60mg | (no batch claim) | 53.24mg | -11.3% | 75.00% | 2025A512-09 | No Label / Silver Crimp / Clear Red Cap | Lab G | Public | |
| 5 Nov 2025 | View | 60mg | (no batch claim) | 69.71mg | +16.2% | 99.90% | 2025A512-09 | No Label / Silver Crimp / Clear Red Cap | Lab G | Public | |
| 23 Oct 2025 | View | 30mg | 37.1mg | 31.2mg | -15.9% | 99.95% | 2025A56-09 | No Label / Silver Crimp / Orange Cap | Lab E | Public | |